Traditional and emerging risk factors for cardiovascular disease

被引：22

作者：

Eaton, CB

机构：

[1] Brown Univ, Mem Hosp Rhode Isl, Pawtucket, RI 02860 USA

[2] Brown Med Sch, Providence, RI 02912 USA

来源：

PRIMARY CARE | 2005年 / 32卷 / 04期

关键词：

D O I：

10.1016/j.pop.2005.09.009

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Cardiovascular disease (CVD) is the leading cause of death in the United States and most western societies, further, approximately 50% of CVD is related to coronary heart disease (CHD). Most CVD results from an athero-thrombotic pathologic process in the body's arterial beds, and is largely preventable through risk factor reduction. Risk factors are diseases, physiologic states, biologic markers, or other identifiable factors associated with increased incidence of CVD. This article breaks down traditional, emerging, and possible risk factors for discussion.

引用

页码：963 / +

页数：15

共 42 条

[1] Task force 1: The ACCF and AHA codes of conduct in human subjects research [J].

Adams, RJ ;

Antman, EM ;

Kavey, REW .

CIRCULATION, 2004, 110 (16) :2512-2516

[2] Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction [J].

Al Suwaidi, J ;

Hamasaki, S ;

Higano, ST ;

Nishimura, RA ;

Holmes, DR ;

Lerman, A .

CIRCULATION, 2000, 101 (09) :948-954

[3] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].

Albert, MA ;

Danielson, E ;

Rifai, N ;

Ridker, PM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70

[4] FETAL ORIGINS OF CORONARY HEART-DISEASE [J].

BARKER, DJP .

BRITISH MEDICAL JOURNAL, 1995, 311 (6998) :171-174

[5] Periodontal disease and coronary heart disease - A reappraisal of the exposure [J].

Beck, JD ;

Eke, P ;

Heiss, G ;

Madianos, P ;

Couper, D ;

Lin, DM ;

Moss, K ;

Elter, J ;

Offenbacher, S .

CIRCULATION, 2005, 112 (01) :19-24

[6] Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis [J].

Clarke, R ;

Collins, R ;

Lewington, S ;

Donald, A ;

Alfthan, G ;

Tuomilehto, J ;

Arnesen, E ;

Bonaa, K ;

Blacher, J ;

Boers, GHJ ;

Bostom, A ;

Bots, ML ;

Grobee, DE ;

Brattström, L ;

Breteler, MMB ;

Hofman, A ;

Chambers, JC ;

Kooner, JS ;

Coull, BM ;

Evans, RW ;

Kuller, LH ;

Evers, S ;

Folsom, AR ;

Freyburger, G ;

Parrot, F ;

Genst, J ;

Dalery, K ;

Graham, IM ;

Daly, L ;

Hoogeveen, EK ;

Kostense, PJ ;

Stehouwer, CDA ;

Hopknis, PN ;

Jacques, P ;

Selhub, J ;

Luft, FC ;

Jungers, P ;

Lindgren, A ;

Lolin, YI ;

Loehrer, F ;

Fowler, B ;

Mansoor, MA ;

Malinow, MR ;

Ducimetiere, P ;

Nygard, O ;

Refsum, H ;

Vollset, SE ;

Ueland, PM ;

Omenn, GS ;

Beresford, SAA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2015-2022

[7] Lipoprotein(a) and coronary heart disease - Meta-analysis of prospective studies [J].

Danesh, J ;

Collins, R ;

Peto, R .

CIRCULATION, 2000, 102 (10) :1082-1085

[8] Measurement of arterial wall thickness as a surrogate marker for atherosclerosis [J].

de Groot, E ;

Hovingh, GK ;

Wiegman, A ;

Duriez, P ;

Smit, AJ ;

Fruchart, JC ;

Kastelein, JJP .

CIRCULATION, 2004, 109 (23) :33-38

[9]

Eaton C B, 1992, J Am Board Fam Pract, V5, P31

[10]

Eaton C B, 1995, Arch Fam Med, V4, P323, DOI 10.1001/archfami.4.4.323

← 1 2 3 4 5 →